Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
277 results
  • StatPearls: Almotriptan [BOOK]
    StatPearls Publishing: Treasure Island (FL) Sidhu Gursharan G Avalon University School of Medicine Patel Priti P Un of Florida College of Pharmacy BOOK
  • Almotriptan is the first FDA-approved drug used to treat migraine headaches in adults with or without an aura.[1] The drug is also useful in adolescents with a history of a migraine that, when left untreated, lasts 4 hours or longer. Certain triptan medications such as almotriptan and rizatriptan have also been shown to be effective and safe for management of acute migraines and other benign head…
  • Almotriptan: a review of 20 years' clinical experience. [Journal Article]
    Expert Rev Neurother 2019; 19(8):759-768Pascual J, Vila C
  • Introduction: Almotriptan (ALT), a serotonin 5-HT1B/1D agonist has been used in the acute treatment of migraine with or without aura for 20 years, accumulating data on more than 15,000 patients in studies and from an estimated >150 million treated migraine attacks in daily clinical practice. The last major review of ALT was written almost 10 years ago. The current narrative review provides an ove…
  • Pharmacotherapy for acute migraines in children and adolescents. [Review]
    Expert Opin Pharmacother 2019; 20(4):455-463Barbanti P, Grazzi L, Egeo G
  • Migraine is increasingly recognized as an extremely burdensome and disabling disorder in both children and adolescents. A proper treatment plan is needed to improve the quality of life of both children and families as well as to minimize the risk of disease progression.
New Search Next